Eastern Cooperative Oncology Group Chair's Office
东部肿瘤合作组主席办公室
基本信息
- 批准号:7262496
- 负责人:
- 金额:$ 64.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-22 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:ABT-627Access to InformationAcetatesAchievementActivity CyclesAcuteAcute Myelocytic LeukemiaAddendumAddressAdjuvantAdministratorAdoptedAdultAdverse eventAdvertisingAdvisory CommitteesAdvocacyAdvocateAfrican AmericanAgeAge-YearsAgreementAirAmendmentAngiogenesis InhibitorsAntineoplastic AgentsApoptosisAppearanceAppendixApplications GrantsAppointmentAreaAtrasentanAttentionAuthorization documentationAutologousAutologous Bone Marrow TransplantationAwardAwarenessBenefits and RisksBiological ProductsBiologyBirdsBlindedBone MarrowBostonBreastBudgetsBusinessesCD34 geneCSF3 geneCancer BiologyCancer CenterCancer PatientCancer Trials Support UnitCancer and Leukemia Group BCancer cell lineCarcinomaCaringCell LineCellsCertificate of ConfidentialityCertificationCharacteristicsChargeChemopreventionChildren&aposs Oncology GroupChromosome abnormalityChronicClassificationClinicClinicalClinical Cancer CenterClinical OncologyClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials Cooperative GroupClinical Trials Data Monitoring CommitteesClinical Trials DesignClosureCodeCollaborationsColorectal CancerCommitCommunicationCommunication ProgramsCommunitiesCommunity Clinical Oncology ProgramCommunity NetworksCommunity PhysicianComplexComputer SecurityConceptionsConditionConduct Clinical TrialsConfidentialityConfidentiality of Patient InformationConflict (Psychology)Conflict of InterestConsciousConsentConsent FormsConstitutionContractsControlled StudyCooperative Research and Development AgreementCorrelative StudyCounselingCountryCuesCyclosporinsCytarabineDailyDalteparinDataData ReportingData SourcesData Storage and RetrievalDatabasesDecision MakingDelawareDenileukin DiftitoxDevelopmentDevelopmental Therapeutics ProgramDexamethasoneDexamethasone/Doxorubicin/PSC 833/VincristineDiagnosisDiagnostic Neoplasm StagingDiarrheaDisclosureDiseaseDisease remissionDisseminated Malignant NeoplasmDocetaxel/DoxorubicinDocetaxel/EstramustineDocetaxel/IrinotecanDoctor of MedicineDoctor of PharmacyDoctor of PhilosophyDocumentationDoseDouble-Blind MethodDrug ApprovalDrug IndustryDrug usageEPO906 (Epothilone B-Novartis)Early DiagnosisEastern Cooperative Oncology GroupEducationEducational MaterialsEducational workshopEffectivenessElderlyElectronic MailElectronicsEmployee StrikesEmploymentEndometrial adenocarcinomaEndometriumEnrollmentEnsureEquilibriumEstramustineEstrogensEthicsEthnic OriginEuropeanEventFaceFacultyFederal GovernmentFellowshipFemaleFilgrastimFire - disastersFloridaFluorouracilFocus GroupsFood, Drug and Cosmetic ActFornet brand of tetrazepamFosteringFoundationsFruitFulvestrantFundingFunding OpportunitiesFutureGemtuzumab OzogamicinGenderGeneticGlioblastomaGoalsGovernmentGovernment regulationsGrantGray unit of radiation doseGroomingGroup MeetingsGroup StructureGrowthGuidelinesHandHead and Neck Squamous Cell CarcinomaHealthHealth FairsHealth Insurance Portability and Accountability ActHealth PlanningHealth StatusHealth educationHematologyHormone ReceptorHormonesHospitalsHumanHuman ResourcesHuman Subject ResearchHydrocortisone/KetoconazoleImatinibImmunoblastic LymphadenopathyImmunologicsIncidenceIndividualIndustryInformation DistributionInformed ConsentInjection of therapeutic agentInstitutesInstitutionInsurance CoverageIntellectual PropertyInterferonsInterleukin-11InternetInterphaseIntravenousInvestigational DrugsJob DescriptionJointsJournalsKnowledgeLabelLaboratoriesLaboratory ResearchLabyrinthLanguageLawyersLeadershipLegalLengthLicensingLifeLinkLiteratureLocal Area NetworksLogisticsLoperamideLymphoblastic LeukemiaMYB geneMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateManufacturer NameMarimastatMarketingMeasuresMediationMedicalMedical centerMedicareMedicineMethodsMinorityMissionModalityModelingMolecularMonitorMonitoring Clinical TrialsMotexafin GadoliniumMovementMucoepidermoid CarcinomaMultiple MyelomaMyeloid LeukemiaNational Cancer InstituteNational Cancer Institute of Canada Clinical Trials GroupNational Surgical Adjuvant Breast and Bowel ProjectNatureNegative Axillary Lymph NodeNeoplasm MetastasisNew AgentsNew EnglandNewly DiagnosedNewsletterNucleotidesOccupational activity of managing financesOctreotideOctreotide Acetate SaltOffice for Human Research ProtectionsOperative Surgical ProceduresOprelvekinOutcomeOxidation-ReductionPamphletsPaperParticipantPathologyPathway interactionsPatient EducationPatient ParticipationPatient RepresentativePatientsPeer ReviewPemetrexedPemetrexed DisodiumPennsylvaniaPeptidesPerformancePersonsPharmaceutical PreparationsPharmacogeneticsPharmacogenomicsPharmacologic SubstancePharmacologyPhasePhase II Clinical TrialsPhase III Clinical TrialsPhiladelphiaPhilosophyPhysiciansPilot ProjectsPlacebosPlayPoliciesPopulationPositioning AttributePostmenopausePreparationPress ReleasesPreventionPrimary Care PhysicianPrincipal InvestigatorPrintingProceduresProcessProduct LabelingProductionProgesteroneProgram EvaluationProteinase-Activated ReceptorsProteomicsProto-Oncogene Proteins c-mybProtocols documentationPublic HealthPublic RelationsPublicationsPuerto RicoPurposeQualifyingQuality of lifeRaceRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRangeRateRecombinantsRecommendationRecording of previous eventsRecordsRecurrenceRefractoryRegistered nurseRegulationRegulatory AffairsRelapseRelative (related person)Replacement TherapyReportingResearchResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResistanceResolutionResource AllocationResourcesRightsRiskRisk FactorsRoleRouteSDZ-PSC-833SafetyScheduleScienceScientistScreening procedureSecureSeleniumServicesSignal TransductionSignal Transduction InhibitionSiteSlideSodiumSolutionsSouth AfricaSouth AmericaSpeedStable DiseaseStaff DevelopmentStagingStandards of Weights and MeasuresState GovernmentStatutes and LawsStem cellsSteroidsStrategic PlanningStructureSuggestionSupplementationSupport GroupsSupport SystemSurveysSystemT-Cell LymphomaTamoxifenTechnologyTelephoneTelevisionThalidomideTherapeuticTherapeutic AgentsTherapeutics CommitteeThinkingTimeTitleTo specifyTodayTouch sensationToxic effectTrainingTraining and EducationTranslational ResearchTransplantationUSA GeorgiaUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States Dept. of Health and Human ServicesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnited States Public Health ServiceUniversitiesUpdateVisionVotingWeekWestern Asia GeorgiaWisconsinWomanWorkWritingYeastsZD1839 (IRESSA)abstractingadvocacy organizationsanastrozoleanti-cancer therapeuticauthoritybasecancer carecancer preventioncancer therapychemotherapeutic agentchemotherapyclinically relevantcollegecomputerized data processingconceptcoralcostcytotoxicdata acquisitiondata managementdaydesigndesiredocetaxeldocument outlinesdosagedrug discoverydrug distributiondrug marketexperiencefallsfarnesyltranstransferasefollow-upfrontiergemcitabinegene therapyglucose transportgranulocytehealth care deliveryhormone therapyhuman subjecthydroxyureaimprovedinnovationinterestkidney celllectureslung small cell carcinomamacrophagemalemalignant breast neoplasmmalignant stomach neoplasmmembernewsnovelolder patientoncologyoutcome forecastpatient advocacy grouppatient orientedpaymentperformance sitepre-clinicalpressurepreventprogramsprospectiveprospectusesprotein farnesyltransferaseprotocol developmentresearch studyresponsesargramostimsoundstatistical centerstemsubcutaneoussuccesssymposiumsymptom managementtooltrial comparingtumoruser-friendlyvolunteerward
项目摘要
DESCRIPTION (provided by applicant): This grant is to provide support for the activities of the Eastern Cooperative Oncology Group (ECOG) Chair, Robert L. Comis, M.D.; the senior scientific leadership of the Group; and programs developed by Dr. Comis to enhance the Group's scientific activity and patient accrual. The activities and specific aims supported by this grant are: to provide high quality senior scientific and administrative medical leadership for ECOG programs, and the infrastructure to support that leadership; to expedite the development and conduct of ECOG Studies; and to improve the opportunity for patient participation in ECOG studies.
描述(由申请人提供):该补助金是为了支持东部肿瘤协作组(ECOG)主席罗伯特·L。Comis,M.D.;集团的高级科学领导;以及由Comis博士开发的项目,以加强集团的科学活动和患者收益。该补助金支持的活动和具体目标是:为ECOG项目提供高质量的高级科学和行政医学领导,以及支持该领导的基础设施;加快ECOG研究的开发和开展;并提高患者参与ECOG研究的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT L COMIS其他文献
ROBERT L COMIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT L COMIS', 18)}}的其他基金
相似海外基金
Improving access to information in perinatal women: Creating and piloting a needs-based information tools
改善围产期妇女获取信息的机会:创建和试点基于需求的信息工具
- 批准号:
23K16469 - 财政年份:2023
- 资助金额:
$ 64.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Is Better Access to Information Effective in Improving Labor Market Outcomes? Experimental Evidence
更好地获取信息是否能有效改善劳动力市场成果?
- 批准号:
1954016 - 财政年份:2019
- 资助金额:
$ 64.45万 - 项目类别:
Standard Grant
Collaborative Research: CESER: EAGER: "FabWave" - A Pilot Manufacturing Cyberinfrastructure for Shareable Access to Information Rich Product Manufacturing Data
合作研究:CESER:EAGER:“FabWave”——用于共享访问信息丰富的产品制造数据的试点制造网络基础设施
- 批准号:
1812687 - 财政年份:2018
- 资助金额:
$ 64.45万 - 项目类别:
Standard Grant
Collaborative Research: CESER: EAGER: "FabWave" - A Pilot Manufacturing Cyberinfrastructure for Shareable Access to Information Rich Product Manufacturing Data
合作研究:CESER:EAGER:“FabWave”——用于共享访问信息丰富的产品制造数据的试点制造网络基础设施
- 批准号:
1812675 - 财政年份:2018
- 资助金额:
$ 64.45万 - 项目类别:
Standard Grant
Is Better Access to Information Effective in Improving Labor Market Outcomes? Experimental Evidence
更好地获取信息是否能有效改善劳动力市场成果?
- 批准号:
1824465 - 财政年份:2018
- 资助金额:
$ 64.45万 - 项目类别:
Standard Grant
Index Herbariorum Upgrade: A Project to Improve Access to Information about the World's Plant and Fungal Collections Assets
Index Herbariorum 升级:改善获取世界植物和真菌收藏资产信息的项目
- 批准号:
1600051 - 财政年份:2016
- 资助金额:
$ 64.45万 - 项目类别:
Standard Grant
TC: Large: Collaborative Research: Facilitating Free and Open Access to Information on the Internet
TC:大型:合作研究:促进互联网上信息的自由和开放获取
- 批准号:
1540066 - 财政年份:2015
- 资助金额:
$ 64.45万 - 项目类别:
Continuing Grant
INEQUALITY IN HIGHER EDUCATION OUTCOMES IN THE UK: SUBJECTIVE EXPECTATIONS, PREFERENCES, AND ACCESS TO INFORMATION
英国高等教育成果的不平等:主观期望、偏好和信息获取
- 批准号:
ES/M008622/1 - 财政年份:2015
- 资助金额:
$ 64.45万 - 项目类别:
Research Grant
Collaborative Access to Information about Physical Objects via See-Through Displays
通过透视显示器协作访问有关物理对象的信息
- 批准号:
413142-2011 - 财政年份:2013
- 资助金额:
$ 64.45万 - 项目类别:
Strategic Projects - Group
Study on the social system for guaranteeing equal access to information in Scandinavia as human rights protection system
斯堪的纳维亚地区保障平等信息的社会制度作为人权保障制度的研究
- 批准号:
24530777 - 财政年份:2012
- 资助金额:
$ 64.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




